Table 3.

Prognostic factors for survival in patients with spinal metastases (excluding myeloma)—univariate analysis (n = 59)

Variable	P
Localisation (cervical vs. thoracic vs. lumbar)	0.371
Primary tumour (rapid vs. intermediate vs. slow)	<0.001*
Pathological fracture (present vs. absent)	0.131
Visceral metastases (present vs. absent)	0.004*
No. of spinal metastases (more than one vs. one)	0.923
No. of extraspinal bone metastases (one or more than one vs. none)	0.457
Karnofsky score (low vs. intermediate vs. high)	0.100
Neurol. symptoms (MRC 0/5–3/5 vs. 4/5–5/5)	0.982
Neurol. symptoms (Frankel’s A–B vs. C–D vs. normal)	0.976

Log-rank test

* Significant at P < 0.05